Role of Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) in the propagation of MPMV vectors by genetic complementation using homologous/heterologous env genes

Virology

Volumn 224, Issue 2, 1996, Pages 517-532

  Rizvi, Tahir A ^a,b   Lew, Kathy A ^a   Murphy Jr , Edwin C ^c   Schmidt, Russell D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c Department of Tumor Biology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENETIC COMPLEMENTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MASON-PFIZER MONKEY VIRUS; MONKEY VIRUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN RETROVIRUS; TYPE D RETROVIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0030588211     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0558     Document Type: Article

References (81)

1. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., and Martin, M. A. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J. Virol. 59, 284-291.
2. Arrigo, S. J., and Chen, I. S. Y. (1991). Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev. 5, 808-819.
3. Arrigo, S., and Beemon, K. (1988). Regulation of Rous sarcoma virus RNA splicing and stability. Mol. Cell. Biol. 7, 4858-4867.
4. Bogerd, H. P., Fridell, R. A., Madore, S., and Cullen, B. R. (1995). Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 82, 485-494.
5. Bray, M., Prasad, S., Dubay, J. W., Hunter, E., Jeang, K.-T., Rekosh, D., and Hammarskjold, M.-L. (1994). A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. USA 4, 1256-1260.
6. Brighty, D. W., and Rosenberg, M. (1994). A cis-acting repressive sequence that overlaps the Rev-responsive element of human immunodeficiency virus type 1 regulates nuclear retention of env mRNA independently of known splice signals. Proc. Natl. Acad. Sci. USA 91, 8314-8318.
7. Buchschacher, G. L., Jr., and Panganiban, A. T. (1992). Human immunodeficiency virus vectors for inducible expression of foreign genes. J. Virol. 66, 2731-2739.
8. Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown-Shimer, S., and Cerami, A. (1986). Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83, 1670-1674.
9. Chen, C.-Y. A., Chen, T.-M., and Shyu, A.-B. (1994). Interplay of two functionally and structurally distinct domains of the c-fos AU-rich element specifies its mRNA-destabilizing function. Mol. Cell. Biol. 14, 416-426.
10. Chen, C.-Y. A., and Shyu, A.-B. (1994). Selective degradation of early-response-gene mRNAs: functional analyses of sequence features of the AU-rich elements. Mol. Cell. Biol. 14, 8471-8482.
11. Chopra, H. C., and Mason, M. M. (1970). A new virus in a spontaneous mammary tumor of a rhesus monkey. Cancer Res. 30, 2081-2086.
12. Cochrane, A. W., Jones, K. S., Beidas, S., Dillon, P. J., Skalka, A. M., and Rosen, C. A. (1991). Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J. Virol. 65, 5305-5313.
13. Coffin, J. (1985). Genome structure. In "Molecular Biology of Tumor Viruses: RNA Tumor Viruses" (R. Weiss, N. Teich, H. Varmus, and J. Coffin, Eds.), 2nd ed., Vol. 2, pp. 17-73. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
14. Cullen, B. R. (1988). Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 152, 684-704.
15. Cullen, B. R. (1992). Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 56, 375-394.
16. D'Agostino, D. M., Felber, B. K., Harrison, J. E., and Pavlakis, G. N. (1992). The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/ env mRNAs. Mol. Cell. Biol. 12, 1375-1386.
17. Daniel, M. D., King, N. W., Letvin, N. L., Hunt, R. D., Sehgal, P. K., and Desrosiers, R. C. (1984). A new type D retrovirus isolated from macaques with an immunodeficiency syndrome. Science 223, 602-605.
18. Delwart, E. L., Buchschacher, G. L., Jr., Freed, E. O., and Panganiban, A. T. (1992). Analysis of HIV-1 envelope mutants and pseudotyping of replication-defective HIV-1 vectors by genetic complementation. AIDS Res. Hum. Retroviruses 8, 1669-1677.
19. Dougherty, J. P., and Temin, H. M. (1988). Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J. Virol. 62, 2817-2822.
20. Emerman, M., Vazeux, R., and Peden, K. (1989). The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell 57, 1155-1165.
21. Felber, B. K., Hadzopoulou-Cladaras, M., Cladaras, C., Copeland, T., and Pavlakis, G. N. (1989). rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86, 1495-1499.
22. Fine, D., and Schochetman, G. (1978). Type D primate retroviruses: A review. Cancer Res. 38, 3123-3139.
23. Fischer, U., Huber, J., Boelens, W. C., Matta, I. W., and Luhrmann, R. (1995). The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82, 475-483.
24. Fritz, C. C., Zapp, M. L., and Green, M. R. (1995). A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature (London) 376, 530-533.
25. Geraghty, R. J., and Panganiban, A. T. (1993). Human immunodeficiency virus type 1 Vpu has a CD4-and an envelope glycoprotein-independent function. J. Virol. 67, 4190-4194.
26. Gibbs, J. S., Regier, D. A., and Desrosiers, R. C. (1994). Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. AIDS Res. Hum. Retroviruses 10, 333-342.
27. Hammarskjold, M. L., Heimer, J., Hammarskjold, B., Sangwan, I., Albert, L., Rekosh, D. (1989). Regulation of human immunodeficiency virus env expression by the rev gene product. J. Virol. 63, 1959-1966.
28. Holland, S. M., Ahmad, N., Maitra, R. K., Wingfield, P., and Venkatesan, S. (1990). Human immunodeficiency virus Rev protein recognizes a target sequence in Rev-responsive element RNA within the context of RNA secondary structure. (1990). J. Virol. 64, 5966-5975.
29. Holland, S. M., Chavez, M., Berstberger, S., and Venkatesan, S. (1992). A specific sequence with a bulged guanosine residue(s) in a stem-bulge-stem structure of Rev-responsive element RNA is required for trans activation by human immunodeficiency virus type 1 Rev. J. Virol. 66, 3699-3706.
30. Hu, W. S., and Temin, H. M. (1990a). Genetic consequences of packaging two RNA genomes in one retroviral particle: Pseudodiploidy and high rate of genetic recombination. Proc. Natl. Acad. Sci. USA 87, 1556-1560.
31. Hu, W. S., and Temin, H. M. (1990b). Retroviral recombination and reverse transcription. Science 250, 1227-1233.
32. Huang, J., and Liang, T. J. (1993). A novel hepatitis B virus (HBV) genetic element with Rev responsive element-like properties that is essential for expression of HBV gene products. Mol. Cell. Biol. 13, 7476-7486.
33. Huang, Z-M., and Benedict Yen, T. S. (1994). Hepatitis B virus RNA element that facilitates accumulation of surface gene transcripts in the cytoplasm. J. Virol. 68, 3193-3199.
34. Jaeger, J. A., Turner, D. H., and Zuker, M. (1989). Improved predictions of secondary structures of RNA. Proc. Natl. Acad. Sci. USA 86, 7706-7710.
35. Jensen, E. M., Zelijadt, I, Chopra, H. C., and Mason, M. M. (1970). Isolation and propagation of a new virus from a spontaneous mammary carcinoma of a rhesus monkey. Cancer Res. 30, 2388-2393.
36. Jones, T. R., and Cole, M. D. (1987). Rapid cytoplasmic turnover of c-myc mRNA: Requirement of the 3′-untranslated sequences. Mol. Cell. Biol. 7, 4513-4521.
37. Katz., R., and Skalka, A. M. (1990). Control of retroviral RNA splicing through maintenance of suboptimal processing signals. Mol. Cell. Biol. 10, 696-704.
38. Kestler, H. W., III, Kodama, T., Ringler, D., Marthas, M., Pedersen, N., Lackner, A., Regier, D., Sehgal, P., Daniel, M., King, N., and Desrosiers, R. C. (1990). Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248, 1109-1112.
39. Kjems, J., Brown, M. Chang, D. D., and Sharp, P. A. (1991). Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev responsive element. Proc. Natl. Acad. Sci. USA 88, 683-687.
40. Kruys, V., Marinx, O., Shaw, G., Deschamps, J., and Huez, G. (1989). Translational blockade imposed by cytokine-derived UA-rich sequences. Science 245, 852-854.
41. Lewis, N., Williams, J., Rekosh, D., and Hammarskjold, M.-L. (1990). Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins. J. Virol. 64, 1690-1697.
42. Maldarelli, F., Martin, M. A., and Strebel, K. (1991). Identification of post transcriptionaly active inhibitory sequences in human immunodeficiency virus type 1 RNA: Novel level of gene regulation. J. Virol. 65, 5732-5743.
43. Malim, M. H., Hauber, J., Le, S.-Y., Maizel, J. V., and Cullen, B. R. (1989a). The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (London) 338, 254-257.
44. Malim, M. H., Bohnlein, S., Fenrick, R., Le, S.-Y., Maizel, J. V., and Cullen, B. R. (1989b). Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species. Proc. Natl. Acad. Sci. USA 86, 8222-8226.
45. Malim, M. H., Tiley, L. S., McCarn, D. F., Rusche, J. R., Hauber, J., and Cullen, B. R. (1990). HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell 60, 675-683.
46. Mansky, L. M., Krueger, A. E., and Temin, H. E. (1995). The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5′ end of the gag gene. J. Virol. 69, 3282-3289.
47. Marsh, J. L., Erfle, M., and Wykes, K. J. (1984). The plC plasmid and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation. Gene 32, 481-485.
48. Marx, P. A., Maul, D. H., Osborn, K. G., Lerche, N. W., Moody, P., Lowenstein, L. J. Henrickson, R. V., Arthur, L. O., Gilden R. V., Gravell, M., London, W. T., Server, J. L., Levy, J. A., Munn, R. J., and Gardner, M. B. (1984). Simian AIDS: Isolation of a type D retrovirus and transmission of the disease. Science 223, 1083-1086.
49. Nasioulas, G., Zolotukhin, A. S., Tabernero, C., Solomin, L., Cunningham, C. P., Pavlakis, G. N., and Felber, B. K. (1994). Elements distinct from the human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. J. Virol. 68, 2986-2993.
50. Ogert, R. A., Lee, L. H., and Beemon, K. L. (1996). Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. J. Virol. 70, 3834-3843.
51. Page, K. A., Landau, N. R., and Littman, D. R. (1990). Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64, 5270-5276.
52. Panganiban, A. T., and Fiore, D. (1988). Ordered interstrand and intrastrand DNA transfer during reverse transcription. Science 241, 1064-1069.
53. Pathak, V. K., and Temin, H. M. (1987). Broad spectrum of in vivo forward mutations, hypermutations, and mutational hot-spots in a retroviral shuttle vector after a single replication cycle: Substitutions, frame shifts, and hypermutations. Proc. Natl. Acad. Sci. USA 87, 6019-6023.
54. Pathak, V. K., and Temin, H. M. (1990). Broad spectrum of in vivo forward mutations, hypermutations, and mutational hot-spots in a retroviral shuttle vector after a single replication cycle: Deletions and deletions with insertions. Proc. Natl. Acad. Sci. USA 87, 6024-6028.
55. Power, M. D., Marx, P. A., Bryant, M. L., Gardner, M. B., Barr, P. J., and Luciw, P. A. (1986). Nucleotide sequence of SRV-1, a type-D simian immunodeficiency virus syndrome retrovirus. Science 231, 1567-1572.
56. Rabbitts, P. H., Forster, A., Stinson, M. A., and Rabbits, T. H. J. (1985). Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNA stability. EMBO J. 4, 3727-3733.
57. Rizvi, T. A., and Panganiban, A. T. (1992a). Propagation of SIV vectors by genetic complementation with a heterologous env gene. AIDS Res. Hum. Retroviruses 8, 89-95.
58. Rizvi, T. A., and Panganiban, A. T. (1992b). Simian immunodeficiency virus vectors: Replication and pseudotyping. J. Med. Primatol. 21, 69-73.
59. Rizvi, T. A., and Panganiban, A. T. (1993). Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J. Virol. 67, 2681-2688.
60. Rizvi, T. A., Schmidt, R. D., Lew, K. A., and Keeling, M.E. (1996). Rev/ RRE-independent Mason-Pfizer monkey virus-constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay. Virology 222, 457-463.
61. Rosen, C. A., Terwilliger, E., Dayton, A., Sodroski, J. G., and Haseltine, W. A. (1988). lntragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 85, 2071-2075.
62. Savant-Bhonsale, S., and Cleveland, D. W. (1992). Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a >20S degradation complex. Genes Dev. 6, 1927-1939.
63. Schwartz, S., Felber, B. K., and Pavlakis, G. N. (1992a). Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J. Virol. 66, 150-159.
64. Schwartz, S., Campbell, M., Nasioulas, G., Harrison, J., Felber, B. K., and Pavlakis, G. N. (1992b). Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol. 66, 7176-7182.
65. Shaw, G., and Kamen, R. (1986). A conserved AU sequence from the 3′-untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659-667.
66. Shyu, A.-B, Greenberg, M. E., and Belasco, J. G. (1989). The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 3, 60-72.
67. Smith, J. K. Cywinski, A., and Taylor, J. M. (1984). Specificity of initiation of plus-strand DNA by Rous sarcoma virus. J. Virol. 52, 314-319.
68. Sonigo, P., Barker, C. S., Hunter, E., and Wain-Hobson, S. (1986). Nucleotide sequences of Mason-Pfizer monkey virus: An immunosuppressive D-type retrovirus. Cell 45, 375-385.
69. Stoltzfus, C. M. (1988). Synthesis and processing of avian sarcoma retrovirus RNA. Adv. Virus Res. 35, 1-37.
70. Stoltzfus, C. M., and Fogarty, S. J. (1989). Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect the accumulation of unspliced RNA. J. Virol. 63, 1669-1676.
71. Stromberg, K., Benveniste, R. E., Arthur, L. O., Rabin, H., Giddens, W. K., Ochs, H. D., Morton, W. R., and Tsai, C. (1984). Characterization of exogenous type D retrovirus from fibrosarcoma of a macaque with simian AIDS and fibromatosis. Science 224, 289-292.
72. Stutz, F., Neville, M., and Rosbash, M. (1995). Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast. Cell 82, 495-506.
73. Tan, W., and Schwartz, S. (1995). The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3′ untranslated region. J. Virol. 69, 2932-2945.
74. Tan, W., Felber, B. K., Zblotukhin, A. S., Pavlakis, G. N., and Schwartz, S. (1995). Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting trans activation element of simian retrovirus type 1. J. Virol. 69, 5607-5620.
75. Temin, H. M. (1992). Origin and general nature of retroviruses. In "Retroviridae(J. A. Levy, Ed.), Vol. 1, pp. 1-18. Plenum, New York.
76. Temin, H. M. (1993). A proposal for a new approach to a preventive vaccine against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90, 4419-4420.
77. Thayer, R. M., Power, M. D., Bryant, M. L., Gardner, M. B., Barr, P. J., and Luciw, P. A. (1987). Sequence relationships of type D retroviruses which cause simian acquired immunodeficiency syndrome. Virology 157, 317-329.
78. Triesman, R. (1985). Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′ element and c-fos 3′ sequence. Cell 42, 889-902.
79. Wilson, T., and Treisman, R. (1988). Removal of poly(A) tail and consequent degradation of c-fos mRNA facilitated by 3′ AU-rich sequence. Nature (London) 366, 396-399.
80. Zolotukhin, A. S., Valentin, A., Pavlakis, G. N., and Felber, B. K. (1994). Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J. Virol. 68, 7944-7952.
81. Zuker, M. (1989). On finding all suboptimal foldings of an RNA molecule. Science 244, 48-52.